Evogene (EVGN) has released an update.
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Evogene Ltd., a computational biology company, has successfully regained compliance with Nasdaq’s Listing Rule by maintaining a minimum bid price of $1.00 per share over 10 consecutive business days. The company specializes in life-science product discovery using AI and big data, with a focus on developing therapeutics, ag-biologicals, crop protection chemicals, and high-grade industrial biofuels through its subsidiaries.
For further insights into EVGN stock, check out TipRanks’ Stock Analysis page.
